The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient

Dermatologic Surgery

Volumn 26, Issue 6, 2000, Pages 577-579

  Kagy, Matthew K ^a,b   Amonette, Rex ^a   Geisse, John K ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ADULT; ARTICLE; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; CASE REPORT; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; SKIN IRRITATION;

ADJUVANTS, IMMUNOLOGIC; AMINOQUINOLINES; BASAL CELL NEVUS SYNDROME; CARCINOMA, BASAL CELL; HUMANS; INTERFERON INDUCERS; MALE; MIDDLE AGED; OINTMENTS; SKIN NEOPLASMS;

EID: 0033916806     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.2000.00003.x     Document Type: Article

References (1)

1. Beutner KR, Geisse JK. Therapeutic response of basal cell carcinoma to the immune response modifier Imiquimod 5% cream. J Am Acad Dermatol 1999;41:1002-7.